Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside

Novavax announced a partnership with Takeda Pharmaceutical to sell up to 250 million doses of NVX‑CoV2373, its COVID-19 vaccine candidate, a year in Japan.As part of the partnership, Novavax (NVAX) …